SEP 24, 2014 2:00 PM PDT

Development and Applications of CRISPR-Cas9 for Genome Editing

Speaker
  • Core Member, Broad Institute of MIT and Harvard; Investigator, McGovern Institute for Brain Research; W. M. Keck Career Development Professor in Biomedical Engineering, MIT
    Biography

       
      Feng Zhang joined the Broad Institute of MIT and Harvard as a core member in January 2011, combining technology development and application to study the role of genetic and epigenetic mechanisms underlying diseases specifically of the nervous system. Along with Jennifer Doudna, George Church, Keith Joung and David Liu, Zhang is a co-founder of Editas Medicine.
      As a graduate student at Stanford, Zhang worked with Karl Deisseroth to invent technologies for dissecting the functional organization of brain circuits. He served as a Junior Fellow at Harvard and did postdoctoral research using synthetic biology to study gene activity during brain development. At the Broad, Zhang takes a synthetic biology approach to understand the development of neuropsychiatric disease, is developing novel genome editing technologies including CRISPR aimed at developing specialized animal models. Zhang is also an investigator at the McGovern Institute for Brain Research at MIT.
      He is a recipient of the Perl/UNC Prize in Neuroscience, the NIH Director's Pioneer award, and the National Science Foundation's Alan T. Waterman award. He has also received technology innovation awards from the McKnight and Damon Runyon foundations, and the International Society for Transgenic Technologies. He received his A.B. in chemistry and physics from Harvard College and his Ph.D. in chemistry from Stanford University.
       
       

    Abstract

    The RNA-guided nuclease Cas9 from the microbial CRISPR adaptive immune system has emerged as an exciting tool for precise genome editing in eukaryotic cells. This presentation will discuss the technical development as well as current and future applications and challenges.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUN 09, 2020 3:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 3:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 6am PT, 9am ET, 3pm CEST The importance of disposable plastic consumables and their overall impact on the experimental workflow of qPCR has been taken into considera...
    Loading Comments...
    Show Resources